Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Delayed Nasdaq
Other stock markets
 03:43:28 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.4738 USD +3.00% Intraday chart for RedHill Biopharma Ltd. +3.65% -67.55%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. News RedHill Biopharma Ltd.
  5. Official Publications
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW